Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
株式のランク #33752
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
株価
$0.4523
最終同期: 2023-03-03
時価総額
$6.97M
変化(1日)
-19.23%
変化(1年)
0.00%
US
取引 Lucira Health, Inc. (LHDX)

カテゴリー

Lucira Health, Inc.(LHDX)のP/S比率
2026 時点のP/S比率 TTM: 0
Lucira Health, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0 です。2026 年末時点でのP/S比率は 0 でした。
Lucira Health, Inc. の P/S 比率の履歴(2026 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率